Endogenous activation of latent collagenase by rheumatoid synovial cells: evidence for a role of plasminogen activator

Z Werb, CL Mainardi, CA Vater… - New England Journal of …, 1977 - Mass Medical Soc
Z Werb, CL Mainardi, CA Vater, ED Harris Jr
New England Journal of Medicine, 1977Mass Medical Soc
To elucidate the mechanism of synovial damage in rheumatoid arthritis, we studied the
activation of latent collagenases released from adherent rheumatoid synovial cells in
culture. Latent enzyme was not complexed with α2 macroglobulin, the principal proteinase
inhibitor in serum, and could be activated by trypsin in the presence of α2, macroglobulin if
sufficient proteinase was added to saturate inhibitor. Latent collagenase bound half as
effectively to collagen fibrils as active enzyme. Plasmin was a threefold better activator of …
Abstract
To elucidate the mechanism of synovial damage in rheumatoid arthritis, we studied the activation of latent collagenases released from adherent rheumatoid synovial cells in culture. Latent enzyme was not complexed with α2 macroglobulin, the principal proteinase inhibitor in serum, and could be activated by trypsin in the presence of α2, macroglobulin if sufficient proteinase was added to saturate inhibitor. Latent collagenase bound half as effectively to collagen fibrils as active enzyme. Plasmin was a threefold better activator of latent enzyme than trypsin and could be generated by addition of plasminogen to synovial-cell cultures. Production of both collagenase and plasminogen activator was inhibited by dexamethasone (10–9 M). These studies emphasize the importance of control of activation in regulating collagenase activity. It is likely that rheumatoid synovium produces both latent collagenase and plasminogen activator; plasmin is activated from its zymogen, plasminogen, present in inflamed tissues, and in turn activates collagenase. (N Engl J Med 296:1017–1023, 1977)
The New England Journal Of Medicine